Increased Mir-203-3p and Reduced Mir-21-5p Synergistically Inhibit Proliferation, Migration, and Invasion in Esophageal Cancer Cells

Yang Xia,Yihui Wang,Qi Wang,Maliha Ghaffar,Yuting Wang,Wang Sheng,Fang Zhang
DOI: https://doi.org/10.1097/cad.0000000000000687
2019-01-01
Anti-Cancer Drugs
Abstract:Dysregulation of miR-203-3p and miR-21-5p has been identified in esophageal cancer (EC). The restoration of miR-203-3p and reduction of miR-21-5p were able to cause tumor suppression. Here, co-transfection of miR-203-3p mimics and miR-21-5p inhibitors led to an extraordinary increased expression of miR-203-3p and synergistically inhibited proliferation, migration, and invasion in EC cells. Moreover, we found that Ran GTPase (Ran) was dramatically inhibited in EC cells treated with the co-transfection of miR-203-3p mimics and miR-21-5p inhibitors. Finally, in-vivo studies showed that overexpression of miR-203-3p, combined with the suppression of miR-21-5p, significantly co-inhibited growth of tumors. The obtained data suggested that the development of miRNA-based combination therapeutics represents a promising cancer treatment strategy.
What problem does this paper attempt to address?